169 related articles for article (PubMed ID: 32850337)
21. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
[TBL] [Abstract][Full Text] [Related]
22. Impact of subsequent screening episodes on the positive predictive value for advanced neoplasia and on the distribution of anatomic subsites of colorectal cancer: A population-based study on behalf of the French colorectal cancer screening program.
Azimafoussé Assogba GF; Jezewski-Serra D; Lastier D; Quintin C; Denis B; Beltzer N; Duport N
Cancer Epidemiol; 2015 Dec; 39(6):964-71. PubMed ID: 26546750
[TBL] [Abstract][Full Text] [Related]
23. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
[TBL] [Abstract][Full Text] [Related]
24. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
26. Improving Australian National Bowel Cancer Screening Program outcomes through increased participation and cost-effective investment.
Worthington J; Lew JB; Feletto E; Holden CA; Worthley DL; Miller C; Canfell K
PLoS One; 2020; 15(2):e0227899. PubMed ID: 32012174
[TBL] [Abstract][Full Text] [Related]
27. Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study.
Siebenhofer A; Plath J; Taubenroth M; Singer S; Hechtner M; Dahlhaus A; Rauck S; Schulz-Rothe S; Koné I; Gerlach FM
BMC Cancer; 2015 Aug; 15():605. PubMed ID: 26314581
[TBL] [Abstract][Full Text] [Related]
28. Fecal immunochemical test in colorectal cancer screening: Colonoscopy findings by different cut-off levels.
Ribbing Wilén H; Blom J; Höijer J; Hultcrantz R
J Gastroenterol Hepatol; 2019 Jan; 34(1):103-112. PubMed ID: 29968937
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for colorectal neoplasms based on colonoscopy and pathological diagnoses of Chinese citizens: a multicenter, case-control study.
Qin M; Ma LQ; Tan J; Chen YR; Zhu LR; Lin R; Hu WL; Li JN; Zhang KH; Wang Y; Li JS; Xiao B; Chen HY; Chen YX; Fang JY
Int J Colorectal Dis; 2015 Mar; 30(3):353-61. PubMed ID: 25518811
[TBL] [Abstract][Full Text] [Related]
30. [Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].
García Martínez M; Binefa Rodríguez G; Milà Díaz N; Rodríguez Moranta F; Gonzalo Diego N; Muñoz Sánchez C; Espinàs Piñol JA; Borràs Andrés JM; Moreno Aguado V
Rev Esp Salud Publica; 2011 Dec; 85(6):593-602. PubMed ID: 22249590
[TBL] [Abstract][Full Text] [Related]
31. Population-based screening for colorectal cancer in Wuhan, China.
Liu S; Wang Y; Wang Y; Duan C; Liu F; Zhang H; Tian X; Ding X; Zhang M; Cao D; Liu Y; Jiang R; Zhuo D; Peng J; Zhu S; Zhao L; Wang J; Wei L; Shi Z
Front Oncol; 2024; 14():1284975. PubMed ID: 38487726
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
[No Abstract] [Full Text] [Related]
33. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
34. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
[No Abstract] [Full Text] [Related]
35. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
[TBL] [Abstract][Full Text] [Related]
36. [Colorectal cancer screening: situation and prospect].
Guo C; Liu Q; Dai M
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 May; 49(5):377-80. PubMed ID: 26081698
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts.
Hübner J; Lewin P; Pritzkuleit R; Eisemann N; Maier W; Katalinic A
Int J Colorectal Dis; 2019 Apr; 34(4):599-605. PubMed ID: 30627848
[TBL] [Abstract][Full Text] [Related]
38. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
[No Abstract] [Full Text] [Related]
39. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
40. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
